OptimizeRx Corporation Common Stock (OPRX) is a publicly traded Healthcare sector company. As of May 21, 2026, OPRX trades at $4.92 with a market cap of $95.51M and a P/E ratio of 17.54. OPRX moved +3.00% today. Year to date, OPRX is -62.26%; over the trailing twelve months it is -58.41%. Its 52-week range spans $3.78 to $22.25. Analyst consensus is strong buy with an average price target of $12.00. Rallies surfaces OPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OPRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OPRX recently traded at $4.92. Market cap is $95.51M. P/E ratio is 17.54. Revenue is $109.43M.
| Metric | Value |
|---|---|
| Price | $4.92 |
| Market Cap | $95.51M |
| P/E Ratio | 17.54 |
| EPS | $0.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.25 |
| 52-Week Low | $3.78 |
| Volume | 1.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $109.43M |
| Net Income | $5.13M |
| Gross Margin | 67.25% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $109.43M | $5.13M | $0.28 |
| 2024 | $92.13M | $-20.11M | $-1.10 |
| 2023 | $71.52M | $-17.57M | $-1.03 |
| 2022 | $62.45M | $-11.44M | $-0.64 |
6 analysts cover OPRX: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.00.